These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 9337444)
1. Amphotericin B lipid complex. Rapp RP; Gubbins PO; Evans ME Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444 [TBL] [Abstract][Full Text] [Related]
2. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities. Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033 [TBL] [Abstract][Full Text] [Related]
3. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Cannon JP; Fiscella R; Pattharachayakul S; Garey KW; De Alba F; Piscitelli S; Edward DP; Danziger LH Invest Ophthalmol Vis Sci; 2003 May; 44(5):2112-7. PubMed ID: 12714650 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature. Martino R Curr Med Res Opin; 2004 Apr; 20(4):485-504. PubMed ID: 15119986 [TBL] [Abstract][Full Text] [Related]
5. The experience is CLEAR. Chandrasekar P Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses. Wingard JR Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244 [TBL] [Abstract][Full Text] [Related]
7. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Drew RH; Dodds Ashley E; Benjamin DK; Duane Davis R; Palmer SM; Perfect JR Transplantation; 2004 Jan; 77(2):232-7. PubMed ID: 14742987 [TBL] [Abstract][Full Text] [Related]
8. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069 [TBL] [Abstract][Full Text] [Related]
9. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197 [TBL] [Abstract][Full Text] [Related]
10. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain. Aguado JM; Lumbreras C; González-Vidal D; Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408 [TBL] [Abstract][Full Text] [Related]
11. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Sharkey PK; Graybill JR; Johnson ES; Hausrath SG; Pollard RB; Kolokathis A; Mildvan D; Fan-Havard P; Eng RH; Patterson TF; Pottage JC; Simberkoff MS; Wolf J; Meyer RD; Gupta R; Lee LW; Gordon DS Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model. Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574 [TBL] [Abstract][Full Text] [Related]
13. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816 [TBL] [Abstract][Full Text] [Related]
14. Renal effects of amphotericin B lipid complex. Luke RG; Boyle JA Am J Kidney Dis; 1998 May; 31(5):780-5. PubMed ID: 9590187 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole. Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429 [TBL] [Abstract][Full Text] [Related]
17. Infrequent occurrence of amphotericin B lipid complex-associated nephrotoxicity in various clinical settings at a university hospital: a retrospective study. Slain D; Miller K; Khakoo R; Fisher M; Wierman T; Jozefczyk K Clin Ther; 2002 Oct; 24(10):1636-42. PubMed ID: 12462292 [TBL] [Abstract][Full Text] [Related]
18. Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Walsh TJ; Whitcomb P; Piscitelli S; Figg WD; Hill S; Chanock SJ; Jarosinski P; Gupta R; Pizzo PA Antimicrob Agents Chemother; 1997 Sep; 41(9):1944-8. PubMed ID: 9303390 [TBL] [Abstract][Full Text] [Related]
19. Amphotericin B formulations: a comparative review of efficacy and toxicity. Hamill RJ Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001 [TBL] [Abstract][Full Text] [Related]
20. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. López-Vélez R; Videla S; Márquez M; Boix V; Jiménez-Mejías ME; Górgolas M; Arribas JR; Salas A; Laguna F; Sust M; Cañavate C; Alvar J; J Antimicrob Chemother; 2004 Mar; 53(3):540-3. PubMed ID: 14739148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]